Showing results (191-200 of 427) with videos related to

Sort By:
Pageof 43
Prostate Cancer and Prostatic Diseases|June 29, 2019
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-upStefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
BJU International|September 18, 2024
Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomesLetizia Maria Ippolita Jannello, Franco Orsi, Stefano Luzzago, et al.
World Journal of Urology|July 20, 2020
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsiesMatteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.
World Journal of Urology|October 23, 2021
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsiesStefano Luzzago, Mattia Luca Piccinelli, Giulia Marvaso, et al.
World Journal of Urology|March 29, 2022
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancerMattia Luca Piccinelli, Stefano Luzzago, Giulia Marvaso, et al.
World Journal of Urology|December 7, 2018
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trialsMatteo Ferro, Giuseppe Di Lorenzo, Ottavio de Cobelli, et al.
Prostate Cancer and Prostatic Diseases|December 15, 2019
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-upStefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
BJU International|March 10, 2020
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findingsStefano Luzzago, Ottavio de Cobelli, Gabriele Cozzi, et al.
Neoplasma|January 11, 2022
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysisGiulia Corrao, Giulia Marvaso, Mattia Zaffaroni, et al.
European Urology Open Science|August 2, 2021
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective StudiesGiulia Marvaso, Stefania Volpe, Matteo Pepa, et al.
Pageof 43